The city of West Valley City, Utah, currently has 13 active clinical trials seeking participants for Breast Cancer research studies.
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
Recruiting
The purpose of this study is to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combination with Fulvestrant in advanced breast cancer patients.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/16/2024
Locations: START - Mountain Region, West Valley City, Utah
Conditions: Advanced Solid Tumor, Breast Cancer